Companies / CRI

CRITICA LIMITED

ASX:CRIMaterials

3.03B shares on issueAppendix 2A · as of 1 Apr 2026$0.019price · delayed$9.7Mmarket cap · indicative

Dilution grade

Runway 2–4 quarters; options/rights overhang 112% of shares; share count grew 13% in 24 months

Cash runway2.8 quarters of funding

Share-count growth (24m)12.7%

Raise cadence (24m)1 cash raise

Options & rights overhang111.7% of shares

In-the-money supply0.0% of shares

Pending proposed issuesnone

CRITICA LIMITED's ordinary share count rose 12.7% between January 2025 and April 2026 to 3.03B shares. The company raised capital once in the 24-month window, receiving A$8.0M in proceeds from a November 2025 issue. Options and rights on issue could convert into 3.38B new shares, equal to 111.7% of the current share count, with 0% in the money and the nearest expiry in November 2027. At the March 2026 quarter the company reported A$5.3M in available cash, representing 2.8 quarters of cover at recent spending rates. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026

111.7%

Max option dilution

0.0%

ITM option dilution

Raises · last 12 months

2.8 qtrs

Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 3.03B per Appendix 2A (1 Apr 2026).

Not enough share-count history to chart.

Cash runway

2.8 qtrs

Two to four quarters of funding at the recent spend rate.

$5.3M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.

Paid plan

Cash runway history

Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.

Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	Total on issue after	Source
25 June 2026	3H · cancellation	CRI : ORDINARY FULLY PAID	3.03B	Appendix 3H
1 Apr 2026	2A · quoted issue	CRI : ORDINARY FULLY PAID	3.03B	Appendix 2A
21 Jan 2026	2A · quoted issue	CRI : ORDINARY FULLY PAID	3.02B	Appendix 2A
21 Jan 2026	3G · unquoted	CRI : ORDINARY FULLY PAID	2.91B	Appendix 3G
18 Dec 2025	3G · unquoted	CRI : ORDINARY FULLY PAID	2.91B	Appendix 3G

Paid plan

Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Join the waitlist

Capital raises

1 cash raise in the last 24 months · 1 in the last 12 months

$8.0M

Capital raise

12 Nov 2025

Paid plan

Full raise history

Issue price, discount, brokers, purpose and tranche detail for every raise on record.

Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

111.7%

Total overhang · of current shares

0.0%

In the money · at current price

3.38B

Potential new shares

Nov 2027

Nearest expiry

Paid plan

Per-line options & expiry cliffs

Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.

Join the waitlist

Director dealings

Date	Director	Type	Shares	Options	Value	Source
7 Apr 2026	Timothy Gordon Armstrong Lindley	Buy	1.8M	—	$42k	3Y notice
22 Jan 2026	Timothy Gordon Armstrong Lindley	Buy	7.7M	7.7M	$200k	3Y notice
22 Jan 2026	Nicholas Luigi Cernotta	Buy	3.8M	3.8M	$100k	3Y notice